Product Information

QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.1278 per EA under NDC 68001018306. Its NADAC has been published 650 times since Jun 4, 2014.

FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE FUMARATE 300 MG TAB

quetiapine
$0.1278per EA

Strength

300 mg/1

NDC

68001018306

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA201109

FDA Approved

3/27/2012

TE Code

AB

On Market Since

2/28/2013

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 650 times since Jun 4, 2014, and over the history we have for it it has declined 69.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1278 per EA
All-time high$0.4513 (Nov 12, 2014)
All-time low$0.1136 (Nov 20, 2024)
52-week high$0.1465
52-week low$0.1265
Median price$0.1749
Average price$0.2136
Largest weekly change-26.7% (Nov 20, 2024)
Weeks tracked650
Tracking sinceJun 4, 2014

Price History

1W

0.0%

1M

+0.2%

3M

-0.6%

6M

-12.8%

1Y

-6.2%

3Y

-13.4%

5Y

-10.3%

All

-69.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by BluePoint Laboratories, is $0.1278 per EA (NDC 68001018306), effective Nov 11, 2026.

How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?

Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 69.9%. It has been tracked across 650 weekly CMS publications since Jun 4, 2014.

What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?

Since Jun 4, 2014, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1136 (Nov 20, 2024) to a high of $0.4513 (Nov 12, 2014), with a median of $0.1749 per EA.

Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QUETIAPINE FUMARATE 300 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures QUETIAPINE FUMARATE 300 MG TAB?

QUETIAPINE FUMARATE 300 MG TAB (NDC 68001018306) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.